Recruiting

Rutgers University Study of the Genetics of Breast Cancer.

The goal of this observational study is to learn more about how genes impact the risk of breast cancer. Anyone 18 or older living in the US is eligible, and a diagnosis of cancer is NOT required. Study participation is online, and it takes about 20 minutes to complete health surveys and request a saliva collection kit sent through US mail. In return, study participants may opt to receive information about their genetic ancestry at no cost.

ClinicalTrials.gov IDNCT06773897

PhaseNot Applicable

Enrollment25000

SponsorRutgers, The State University of New Jersey

Age18 Years

SexALL

I'm interested View official listing

Conditions studied

Breast Cancer Risk, Breast Cancer Prevention, Breast Cancer

About this study

Interventions

Genetic: Saliva sample — Saliva sample is sent via prepaid US Mail for DNA extraction
Other: Health Surveys — Health surveys are filled out online in the study portal.

Primary outcomes

Genetic risk variants associated with breast cancer (2 years)

Eligibility information

Inclusion Criteria: * age 18 years or older * currently living in the United States * able to understand and follow written instructions in English * have access to the internet and a computer, laptop, tablet or smart phone * willing to provide written informed consent for participation * willing to provide DNA via a saliva sample using a collection kit mailed to the study participant's home * willing to complete a survey with questions about health related to the study of breast cancer. Exclusion Criteria: * Not able to meet or fulfill any of the inclusion criteria

Study locations

Rutgers University, Piscataway, New Jersey 08854 United States

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.